Results 181 to 190 of about 5,752,243 (395)

Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade‐Offs

Clinical Pharmacology &Therapeutics, EarlyView.
The purpose of this study was to describe the perspectives and trade‐offs of EU regulators about expedited approvals for treatments of patients with advanced cancer. The study consisted of a cross‐sectional survey with assessors and experts from the network of the European Medicines Agency (EMA).
Francesco Pignatti, Filip Josephson, Pierre Demolis, Olli Tenhunen, Elias Péan, Douwe Postmus   +5 more
wiley   +1 more source

Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications

Blood Cancer Journal, 2021
Hiroto Ohguchi, Teru Hideshima, Kenneth C. Anderson   +2 more
doaj   +1 more source

Multiple Myeloma Treated with Stilbamidine and Pentamidine [PDF]

, 1948
A. E. Brewer
openalex   +1 more source

Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis

Cytometry Part A, EarlyView.
ABSTRACT Systemic mastocytosis (SM) is a neoplastic disease characterized by abnormal mast cell (MC) activation and proliferation. Accurate diagnosis often relies on flow cytometry to detect aberrant CD25, CD2, and CD30 expression on MCs in bone marrow (BM).
Abdulrazzaq Alheraky, Kees Meijer, Marije T. Nijk, Saskia K. Klein, Hanneke N. G. Oude Elberink, Ido P. Kema, André B. Mulder   +6 more
wiley   +1 more source

Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma

Blood Cancer Journal
The main objective of this multi-institutional study is to understand the effect of primary intravenous immunoglobulin (IVIG) replacement on clinical outcomes in recipients of BCMA-directed bispecific antibody (bsAb), where infection remains an important
Meera Mohan, Aniko Szabo, Heloise Cheruvalath, Anna Clennon, Vineel Bhatlapenumarthi, Anannya Patwari, Metodi Balev, Divaya Bhutani, Asis Shrestha, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Anup Trikannad, Sruthi Vellanki, Samer Al-Hadidi, Suzanne Lentzsch, Frits van Rhee, Aishee Bag, Anita D’Souza, Nishi Shah, Rajshekhar Chakraborty, Mansi R. Shah, Carolina Schinke   +22 more
doaj   +1 more source

A case of multiple myeloma (myelomatosis) with Bence-Jones proteid in the urine [PDF]

, 1904

openalex   +1 more source

Enhancing detection of central nervous system involvement in multiple myeloma: A novel multidimensional dot‐plot based analysis for flow cytometry

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Central nervous system (CNS) involvement in multiple myeloma (MM) is a rare but severe complication with a poor prognosis. The identification of malignant plasma cells in cerebrospinal fluid (CSF) is essential for early diagnosis and intervention.
Bettina Palicskó, Luca Janovák, László Rejtő, László Váróczy, Zsuzsanna Hevessy, Bettina Kárai   +5 more
wiley   +1 more source

Multiple Myeloma [PDF]

, 1935
Tom A. Outland, Joseph B. Cady
openalex   +1 more source

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy, G. Giblin, A. Gray, N. Starr, L. Murphy, D. O'Sullivan, E. Kavanagh, C. Howley, C. Tracey, E. Morrin, A. McDaid, A. Clarke, J.O. O'Neill, E. Joyce, M. O'Connell, N. G. Mahon   +15 more
wiley   +1 more source

Multiple-myeloma proteins.III. The antigenic relationship of Bence Jones proteins to normal gamma-globulin and multiple-myeloma serum proteins

, 1956
Leonhard Korngold, Rose Lipari
openalex   +1 more source